eGVHD vs SOHO365
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
eGVHD
This educational tool assists healthcare professionals in assessing and scoring the severity of graft versus host disease (GVHD) in allogeneic stem cell transplantation recipients. It uses an algorithm-driven approach to apply internationally recognized criteria, providing differential information and automatic summaries to aid diagnosis.
- Algorithm-driven assessment
- GVHD severity scoring
- Differential information display
- Automatic summary generation
- Educational tool for clinicians
Read full descriptionHide full description
The “eGVHD App” is developed by the UZ Leuven (Belgium) in collaboration with the EBMT (European Bone Marrow Transplantation Society) Transplantation Complications Working Party and the National Institute of Health (Bethesda, USA). It is an electronic tool designed as an algorithm-driven application, to help clinicians apply the internationally recognized criteria for the assessment of graft versus host disease (GVHD), a pleiotropic disease affecting allogeneic stem cell transplantation recipients when their transplanted stem cells react against their own body. This app is not a medical tool aiming at replacing the diagnosis of a clinician, but a user-friendly educational tool. It helps health care professionals improve their ability to diagnose and score the severity of GVHD by showing the user differential information and it making an automatic summary of what has been filled in.
SOHO365
Connect with a global community of hematologic oncology professionals. Access a comprehensive resource center with slides, publications, and videos. Stay updated with the latest news and journal articles, and manage event registrations and reminders.
- Global professional community access
- Comprehensive resource center
- Hematologic oncology discussions
- Access to official journal and news
- Event information and registration
- Customizable reminders and alerts
Read full descriptionHide full description
The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, approximately 8,000 members from 110 countries have joined the society from around the globe. SOHO is a global society designed specifically for clinicians, research scientists and related health care professionals who specialize in the research and treatment of patients with hematologic malignancies. SOHO’s mission is to expedite worldwide research and education through the exchange of scientific information. Organized by its founders and world class committees, SOHO is the only society specific to this field. SOHO represents physicians and other professionals from all corners of the world. SOHO is leading vital efforts to further treatments for those with hematologic malignancies. Become a SOHO Member free-of-charge. Join us and experience the benefits of membership at http://sohoonline.org ! Mobile app features: • Instant connections to our SOHO Community of nearly 8,000 members • Access to a comprehensive Resource Center that includes slides, publications, abstracts, videos and more • Connection to our SOHO DocMatter Community for hematologic oncology discussions, questions and education • Access to our official journal, ‘Clinical Lymphoma Myeloma and Leukemia’and our news publication, 'Blood Cancers Today' • Direct access to event information and registration with significant member-only discounts • Set SOHO reminders and receive alerts within the App • Connect to the App through Facebook, LinkedIn, and Twitter
Screenshots
Verdict
The clearest difference is update cadence: SOHO365 at every 5 weeks against eGVHD's every 16 months. eGVHD's advantage is monetization model (free vs free with in-app purchases) and iOS requirement (9.0 vs 15.0). On price, rating, ratings volume and ads there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
On the App Store both sit at effectively the same score — 5.0 for eGVHD against 5.0 for SOHO365. Both are backed by a comparable volume of ratings — 2 and 2 respectively.
eGVHD ships an update every 16 months, SOHO365 every 5 weeks. The most recent releases landed on September 16, 2026 and October 3, 2026 respectively.
| Parameter | eGVHD | SOHO365 |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (2 ratings) | 5.0 (2 ratings) |
| Number of ratings | 2 | 2 |
| Update frequency | Every 16 months | Every 5 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free — better | Free with in-app purchases |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 9.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 81 MB | 55 MB |
| Age rating | 17+ | 17+ |
| Developer | nexuzhealth NV | SOCIETY OF HEMATOLOGIC ONCOLOGY |
Customer experience
eGVHD
SOHO365
In-app purchases
eGVHD
No in-app purchases
SOHO365
No in-app purchases








